ACI Formulations Statistics

Total Valuation

ACI Formulations has a market cap or net worth of BDT 5.74 billion. The enterprise value is 9.03 billion.

Market Cap	5.74B
Enterprise Value	9.03B

Important Dates

The next estimated earnings date is Wednesday, January 29, 2025.

Earnings Date	Jan 29, 2025
Ex-Dividend Date	Nov 18, 2024

Share Statistics

ACI Formulations has 47.25 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	47.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.54%
Owned by Institutions (%)	n/a
Float	16.06M

Valuation Ratios

The trailing PE ratio is 16.02.

PE Ratio	16.02
Forward PE	n/a
PS Ratio	1.22
PB Ratio	1.70
P/TBV Ratio	1.71
P/FCF Ratio	27.48
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.01, with an EV/FCF ratio of 43.25.

EV / Earnings	25.21
EV / Sales	1.92
EV / EBITDA	13.01
EV / EBIT	13.99
EV / FCF	43.25

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 1.06.

Current Ratio	1.24
Quick Ratio	0.87
Debt / Equity	1.06
Debt / EBITDA	5.16
Debt / FCF	17.15
Interest Coverage	2.89

Financial Efficiency

Return on equity (ROE) is 11.03% and return on invested capital (ROIC) is 6.31%.

Return on Equity (ROE)	11.03%
Return on Assets (ROA)	5.48%
Return on Capital (ROIC)	6.31%
Revenue Per Employee	4.56M
Profits Per Employee	346,532
Employee Count	1,034
Asset Turnover	0.64
Inventory Turnover	2.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.61% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.61%
50-Day Moving Average	120.69
200-Day Moving Average	128.32
Relative Strength Index (RSI)	49.58
Average Volume (20 Days)	20,785

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ACI Formulations had revenue of BDT 4.72 billion and earned 358.31 million in profits. Earnings per share was 7.58.

Revenue	4.72B
Gross Profit	1.48B
Operating Income	645.74M
Pretax Income	474.04M
Net Income	358.31M
EBITDA	694.32M
EBIT	645.74M
Earnings Per Share (EPS)	7.58

Full Income Statement

Balance Sheet

The company has 291.55 million in cash and 3.58 billion in debt, giving a net cash position of -3.29 billion or -69.67 per share.

Cash & Cash Equivalents	291.55M
Total Debt	3.58B
Net Cash	-3.29B
Net Cash Per Share	-69.67
Equity (Book Value)	3.37B
Book Value Per Share	71.30
Working Capital	1.02B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 333.44 million and capital expenditures -124.54 million, giving a free cash flow of 208.90 million.

Operating Cash Flow	333.44M
Capital Expenditures	-124.54M
Free Cash Flow	208.90M
FCF Per Share	4.42

Full Cash Flow Statement

Margins

Gross margin is 31.33%, with operating and profit margins of 13.69% and 7.60%.

Gross Margin	31.33%
Operating Margin	13.69%
Pretax Margin	10.05%
Profit Margin	7.60%
EBITDA Margin	14.72%
EBIT Margin	13.69%
FCF Margin	4.43%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 1.65%.

Dividend Per Share	2.00
Dividend Yield	1.65%
Dividend Growth (YoY)	-20.00%
Years of Dividend Growth	n/a
Payout Ratio	34.18%
Buyback Yield	n/a
Shareholder Yield	1.65%
Earnings Yield	6.24%
FCF Yield	3.64%

Dividend Details

Stock Splits

The last stock split was on November 21, 2021. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 21, 2021
Split Type	Forward
Split Ratio	1.05

Scores

ACI Formulations has an Altman Z-Score of 2.13. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.13
Piotroski F-Score	n/a